SETDB1 and hepatocellular carcinoma: In addition to miR-29, miR-621 has been shown to reduce SETDB1 expression by directly targeting the 3′-UTR of SETDB1 and enhancing the radiosensitivity of HCC cells (Shao et al., 2019).